Chowist Web Search

Search results

  1. Results From The WOW.Com Content Network
  2. Insys Therapeutics - Wikipedia

    en.wikipedia.org/wiki/Insys_Therapeutics

    Insys Therapeutics. Founded in 1990, Insys Therapeutics was an American specialty pharmaceutical company based in Chandler, Arizona. [ 1] Its main product was Subsys, a sublingual liquid form of the drug fentanyl. Fentanyl is an extremely fast-acting and powerful opioid used to relieve peaks of pain in cancer patients. [ 2][ 3]

  3. Florida doctor accepted $160K in bribes to prescribe ... - AOL

    www.aol.com/florida-doctor-accepted-160k-bribes...

    Insys Therapeutics, Inc. paid Lubin to issue prescriptions for Subsys, its product meant to “treat breakthrough cancer pain,” the attorney’s office said in September 2021, when the lawsuit ...

  4. Here's Why You've Never Heard Of The Drug At The Center Of ...

    www.aol.com/heres-why-youve-never-heard...

    Lonafen is actually based off of a real medication called Subsys, a fentanyl spray, which was made by Insys Therapeutics, an Arizona-based pharmaceutical company. The drug was released onto the ...

  5. The True Story and Criminal Case Behind ‘Pain Hustlers’ - AOL

    www.aol.com/lifestyle/true-story-criminal-case...

    The article detailed the various techniques that the pharmaceutical company Insys Therapeutics used to push its highly addictive fentanyl-based painkiller Subsys into the marketplace, including ...

  6. John Kapoor - Wikipedia

    en.wikipedia.org/wiki/John_Kapoor

    John Nath Kapoor(born 1942/1943) is an American multi-millionaire, pharmaceutical entrepreneur, former CEO of Insys Therapeutics, and majority shareholder in the generic drug manufacturing company Akorn.[2] In the fall of 2017, Kapoor was arrested and charged with numerous felony counts including RICOconspiracy, conspiracy to commit wire fraud ...

  7. 'Greed' fuelled Insys founder's opioid bribe scheme - prosecutor

    www.aol.com/news/insys-founder-ran-bribe-scheme...

    A lawyer for Insys Therapeutics Inc's one-time billionaire founder on Monday denied that he had any role in the U.S. opioid crisis as a federal prosecutor told jurors he ran a scheme to bribe ...

  8. INSYS Gets Negative FDA Recommendation for Pain Candidate - AOL

    www.aol.com/news/insys-gets-negative-fda...

    INSYS Therapeutics' (INSY) NDA for buprenorphine sublingual spray fails to get recommendation for approval for treating moderate-to-severe acute pain after bunionectomy from FDA advisory committee.

  9. List of off-label promotion pharmaceutical settlements

    en.wikipedia.org/wiki/List_of_off-label...

    In August 2015, Insys Therapeutics reached a $1.1 million settlement with the Oregon Department of Justice, resolving allegations that it promoted its opioid drug Subsys to treat off-label non-cancer uses that were not approved by the FDA. Insys has also paid New Hampshire $2.9 million to settle allegations of aggressive marketing of Subsys.